Skip to content
The Bio Report cover art

All episodes

The Bio Report, 641 episodes. Page 3 of 7.

#
Title
201

Treating Psychiatric Conditions with Tripless Psychedelics

202

How AI Is Finding Its Way into Unexpected Places in Biopharma Companies

203

Searching the Dark Matter of the Proteome to Develop New Therapies

204

The Year in Biotech and What’s Ahead in 2023

205

Targeting a Novel Checkpoint to Treat Cancer and Autoimmune Conditions

206

The Growing Need for Biosecurity Vigilance

207

Enlisting Next-Generation Cytokine Immunotherapies in the Fight Against Cancer

208

Engineering Safer and More Effective Cell Therapies

209

Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens

210

Using Virtual Reality-Guided Mindfulness to Treat Chronic Pain in Cancer Patients

211

Activating the Adaptive and Innate Immune Systems to Fight Cancer

212

A Longevity Fund Focused on Young Companies

213

Learning from “Elite” Responders to Develop Better Immunotherapies

214

Bringing Precision Medicine to the Treatment of Obesity

215

Expanding the Promise of RNA Therapies

216

Triggering a Systemic Immune Response Against Cancer

217

Targeting RNA Dysregulation in Cancer

218

Building a Pipeline of Next-Generation Kinase Inhibitors

219

Rethinking How Cell and Gene Therapies Are Made to Improve Accessibility

220

Developing Next-Generation Radiopharmaceuticals

221

Why Great Science and Data Aren’t Enough

222

Targeting Sugars that Let Cancers Evade the Immune System

223

Engineering Stem Cells to Withstand Targeted Therapies

224

Targeting a Convergence of Signaling Pathways that Drive the Growth and Spread of Cancer

225

Moving from Preservation to Restoration with Off-the-Shelf Cell Therapies

226

Using Gene Therapies to Treat Chronic, Inflammatory Conditions

227

Unlocking the Full Potential of Antibody Therapies

228

Combatting Superbugs and Emerging Viruses

229

How a Plant-Derived Gel Halts Bleeding in Seconds

230

Exploiting a Vulnerability in Cancers

231

Democratizing AI

232

A Rapid Onset Nasal Spray to Treat Mental Health Conditions

233

A Regenerative Medicine Company Puts Its Off-the-Shelf Vessel Replacements to the Test in Ukraine

234

Battling Resistance in Tumors with “Pan-Variant” Kinase Inhibitors

235

Treating Disease by Editing Genes in the Microbiome

236

Embracing the Promise of Natural Killer Cells in the Fight Against Cancer

237

Addressing Neurodegenerative Disease by Suppressing a Hyper Immune Response

238

Bringing Precision Medicine to Psychiatry

239

Attacking Neurodegenerative Diseases with Protein Degraders

240

Restoring Immune Activity While Suppressing Cancer Proliferation

241

A New Model for Preventing Life-Threatening Blood Clots

242

The Race to Live Forever

243

A Model for Moving from Breakthrough to Blockbuster

244

Building the Next-Generation of Cell and Gene Therapies

245

Building Small Molecule Drugs that Are Superior to Biologics

246

A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action

247

A Pursuit of Off-The-Shelf CAR-T Therapies

248

Mapping the Human Proteome

249

Gene Therapy Provides Hope to Hemophilia B Patients

250

Making Data-Driven Medicine a Reality

251

A Neuroscientist Turned Venture Investor Discusses TechBio Investing

252

A Nonprofit Seeks to Make Cell and Gene Therapies Affordable Worldwide

253

Disposing Toxic Proteins to Treat Neurodegenerative Diseases

254

Repurposing a Drug for Parasitic Infections as a Targeted GI Therapy

255

Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging

256

The Year in Biotech and What’s Ahead in 2022

257

Restoring the Guardian of the Genome to Fight Tumors

258

Advancing a Cell Therapy with the Potential to Cure HIV

259

Harnessing More Efficient Organisms to Reshore BioManufacutring

260

Using Digital Health Technology to Bring the Trial to the Patient

261

Using the Body’s Housecleaning Mechanism to Target Undruggable Proteins

262

Advocating for the Extension of Healthy Life

263

Using Donated Living Skin as an Alternative to Animal Testing

264

A Platform to Scale the Production of Personalized Cell Therapies

265

Developing Small Molecule Therapies to Target Proteins Only Biologics Have Been Able to Hit

266

Targeting Solid Tumors with Oncolytic Viruses

267

Reinventing the Discovery and Cell Line Development of Biotherapeutics

268

Engineering Off-the-Shelf Cell Therapies to Target Solid Tumors

269

Democratizing Drug Discovery

270

Scaling Genetic Counseling Services with AI

271

Programming Cell Therapies to Overcome Solid Tumor Defense Systems

272

Using Liquid Biopsies to Diagnose Infectious Diseases

273

Striking Hepatitis B at Its Core

274

Modulating Serotonin with Psychedelics to Treat Neuropsychiatric Conditions

275

A Procedural Therapy Seeks to Address Type 2 Diabetes at Its Root Cause

276

Building a Better Path to Neurotherapeutics

277

Taking a Portfolio Approach to Immuno-Oncology

278

Engineering Life to Reach New Worlds

279

Targeting Cancer Drug Side Effects at Their Source

280

Mapping the Universe of Human Proteins

281

Fighting Disease by Modulating the Translation of Proteins

282

Fixing Biopharma’s R&D Productivity by Taking a Cue from the Tech Industry

283

An Affordable and Widely Available Drug Offers Global Hope against COVID

284

A Gene Therapy to Program the Body to Produce a Treatment for Osteoarthritis

285

A Test for Data-Driven Drug Development

286

Bridging the Gulf Between the Promise and Reality of Precision Health

287

Using Synthetic Biology to Craft One-Time, Programmable mRNA Therapeutics

288

Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease

289

Disrupting Pain Signals with Precision

290

A Diagnostics Company Moves to Developing Precision Cancer Therapies

291

Characterizing the Immunome at Scale

292

Delivering Oxygen to Tissue in Need

293

Using Gene Therapy to Create a Drug Biofactory within a Patient

294

Finding New Uses for TNF Inhibitors

295

Using AI to Map the Undiscovered World of Bioactive Compounds in Plants

296

Improving the Delivery of Drugs through Thin Film Freezing

297

Using CRISPR to Target RNA Instead of DNA

298

An Antisense Pioneer Brings Custom Treatments to Patients with Ultra-Rare Conditions

299

Managing Neurodegenerative Diseases with Better Data to Improve Outcomes

300

A Small Molecule Cancer Drug That Promotes an Adaptive Immune Response